APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pathology Image Analysis System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pathology Image Analysis System Market Outlook and Growth Opportunities 2026

12 August 2026190 pages

Choose your research edition.

Industry ResearchPathology Image Analysis System Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Pathology Image Analysis System Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Pathology Image Analysis System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pathology Image Analysis System Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pathology Image Analysis System Market Analysis and Forecast 2026-2032176 pages · $4,950 USD

Market perspective

The global Pathology Image Analysis System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pathology Image Analysis System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pathology Image Analysis System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pathology Image Analysis System market include CellCarta, Roche Digital Pathology, 3DHISTECH Ltd., Augmentiqs, microDimensions, Leica Biosystems, Visiopharm and Aiforia, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pathology Image Analysis System market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pathology Image Analysis System and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pathology Image Analysis System revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pathology Image Analysis System market.

Pathology Image Analysis System Segment by Company

CellCarta

Roche Digital Pathology

3DHISTECH Ltd.

Augmentiqs

microDimensions

Leica Biosystems

Visiopharm

Aiforia

Pathology Image Analysis System Segment by Type

Cloud-Based

On-Premises

Pathology Image Analysis System Segment by Application

Hospital

Clinic

Others

Pathology Image Analysis System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pathology Image Analysis System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pathology Image Analysis System key companies, revenue, market share, and recent developments.

3. To split the Pathology Image Analysis System breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pathology Image Analysis System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pathology Image Analysis System significant trends, drivers, influence factors in global and regions.

6. To analyze Pathology Image Analysis System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pathology Image Analysis System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pathology Image Analysis System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pathology Image Analysis System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pathology Image Analysis System industry.

Chapter 3: Detailed analysis of Pathology Image Analysis System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pathology Image Analysis System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pathology Image Analysis System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pathology Image Analysis System Industry Trends Table 2. Pathology Image Analysis System Industry Drivers Table 3. Pathology Image Analysis System Industry Opportunities and Challenges Table 4. Pathology Image Analysis System Industry Restraints Table 5. Global Pathology Image Analysis System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pathology Image Analysis System Revenue Share by Company (2021-2026) Table 7. Global Pathology Image Analysis System Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pathology Image Analysis System Key Company Manufacturing Base & Headquarters Table 9. Global Pathology Image Analysis System Company, Product Type & Application Table 10. Global Pathology Image Analysis System Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pathology Image Analysis System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-Based Table 15. Significant Companies of On-Premises Table 16. Global Pathology Image Analysis System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pathology Image Analysis System Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pathology Image Analysis System Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pathology Image Analysis System Sales Value Share by Type (2021-2026) Table 20. Global Pathology Image Analysis System Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Others Table 24. Global Pathology Image Analysis System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pathology Image Analysis System Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pathology Image Analysis System Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pathology Image Analysis System Sales Value Share by Application (2021-2026) Table 28. Global Pathology Image Analysis System Sales Value Share by Application (2027-2032) Table 29. Global Pathology Image Analysis System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pathology Image Analysis System Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pathology Image Analysis System Sales Value Share by Region (2021-2026) Table 32. Global Pathology Image Analysis System Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pathology Image Analysis System Sales Value Share by Region (2027-2032) Table 34. Global Pathology Image Analysis System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pathology Image Analysis System Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pathology Image Analysis System Sales Value Market Share by Country (2021-2026) Table 37. Global Pathology Image Analysis System Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pathology Image Analysis System Sales Value Market Share by Country (2027-2032) Table 39. CellCarta Company Information Table 40. CellCarta Business Overview Table 41. CellCarta Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. CellCarta Pathology Image Analysis System Product Portfolio Table 43. CellCarta Recent Development Table 44. Roche Digital Pathology Company Information Table 45. Roche Digital Pathology Business Overview Table 46. Roche Digital Pathology Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Roche Digital Pathology Pathology Image Analysis System Product Portfolio Table 48. Roche Digital Pathology Recent Development Table 49. 3DHISTECH Ltd. Company Information Table 50. 3DHISTECH Ltd. Business Overview Table 51. 3DHISTECH Ltd. Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. 3DHISTECH Ltd. Pathology Image Analysis System Product Portfolio Table 53. 3DHISTECH Ltd. Recent Development Table 54. Augmentiqs Company Information Table 55. Augmentiqs Business Overview Table 56. Augmentiqs Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Augmentiqs Pathology Image Analysis System Product Portfolio Table 58. Augmentiqs Recent Development Table 59. microDimensions Company Information Table 60. microDimensions Business Overview Table 61. microDimensions Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. microDimensions Pathology Image Analysis System Product Portfolio Table 63. microDimensions Recent Development Table 64. Leica Biosystems Company Information Table 65. Leica Biosystems Business Overview Table 66. Leica Biosystems Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Leica Biosystems Pathology Image Analysis System Product Portfolio Table 68. Leica Biosystems Recent Development Table 69. Visiopharm Company Information Table 70. Visiopharm Business Overview Table 71. Visiopharm Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Visiopharm Pathology Image Analysis System Product Portfolio Table 73. Visiopharm Recent Development Table 74. Aiforia Company Information Table 75. Aiforia Business Overview Table 76. Aiforia Pathology Image Analysis System Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Aiforia Pathology Image Analysis System Product Portfolio Table 78. Aiforia Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Pathology Image Analysis System Product Image Figure 2. Global Pathology Image Analysis System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pathology Image Analysis System Market Size (2021-2032) & (US$ Million) Figure 4. Global Pathology Image Analysis System Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-Based Image Figure 8. On-Premises Image Figure 9. Global Pathology Image Analysis System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pathology Image Analysis System Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pathology Image Analysis System Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Pathology Image Analysis System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pathology Image Analysis System Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pathology Image Analysis System Sales Value Share by Application (2021-2032) Figure 18. Global Pathology Image Analysis System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pathology Image Analysis System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pathology Image Analysis System Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pathology Image Analysis System Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pathology Image Analysis System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based
  • On-Premises
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • CellCarta
  • Roche Digital Pathology
  • 3DHISTECH Ltd.
  • Augmentiqs
  • microDimensions
  • Leica Biosystems
  • Visiopharm
  • Aiforia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pathology Image Analysis System Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pathology Image Analysis System Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pathology Image Analysis System Market Dynamics
  1. 2.1 Pathology Image Analysis System Industry Trends
  2. 2.2 Pathology Image Analysis System Industry Drivers
  3. 2.3 Pathology Image Analysis System Industry Opportunities and Challenges
  4. 2.4 Pathology Image Analysis System Industry Restraints
3 Pathology Image Analysis System Market by Company
  1. 3.1 Global Pathology Image Analysis System Company Revenue Ranking in 2025
  2. 3.2 Global Pathology Image Analysis System Revenue by Company (2021-2026)
  3. 3.3 Global Pathology Image Analysis System Company Ranking (2024-2026)
  4. 3.4 Global Pathology Image Analysis System Company Manufacturing Base and Headquarters
  5. 3.5 Global Pathology Image Analysis System Company Product Type and Application
  6. 3.6 Global Pathology Image Analysis System Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pathology Image Analysis System Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pathology Image Analysis System Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pathology Image Analysis System Market by Type
  1. 4.1 Pathology Image Analysis System Type Introduction
  2. 4.1.1 Cloud-Based
  3. 4.1.2 On-Premises
  4. 4.2 Global Pathology Image Analysis System Sales Value by Type
  5. 4.2.1 Global Pathology Image Analysis System Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pathology Image Analysis System Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pathology Image Analysis System Sales Value Share by Type (2021-2032)
5 Pathology Image Analysis System Market by Application
  1. 5.1 Pathology Image Analysis System Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Pathology Image Analysis System Sales Value by Application
  6. 5.2.1 Global Pathology Image Analysis System Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pathology Image Analysis System Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pathology Image Analysis System Sales Value Share by Application (2021-2032)
6 Pathology Image Analysis System Regional Value Analysis
  1. 6.1 Global Pathology Image Analysis System Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pathology Image Analysis System Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pathology Image Analysis System Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pathology Image Analysis System Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pathology Image Analysis System Sales Value (2021-2032)
  7. 6.3.2 North America Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pathology Image Analysis System Sales Value (2021-2032)
  10. 6.4.2 Europe Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pathology Image Analysis System Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pathology Image Analysis System Sales Value (2021-2032)
  16. 6.6.2 South America Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pathology Image Analysis System Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pathology Image Analysis System Sales Value Share by Country, 2025 VS 2032
7 Pathology Image Analysis System Country-level Value Analysis
  1. 7.1 Global Pathology Image Analysis System Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pathology Image Analysis System Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pathology Image Analysis System Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pathology Image Analysis System Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pathology Image Analysis System Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pathology Image Analysis System Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pathology Image Analysis System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CellCarta
  2. 8.1.1 CellCarta Company Information
  3. 8.1.2 CellCarta Business Overview
  4. 8.1.3 CellCarta Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CellCarta Pathology Image Analysis System Product Portfolio
  6. 8.1.5 CellCarta Recent Developments
  7. 8.2 Roche Digital Pathology
  8. 8.2.1 Roche Digital Pathology Company Information
  9. 8.2.2 Roche Digital Pathology Business Overview
  10. 8.2.3 Roche Digital Pathology Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Roche Digital Pathology Pathology Image Analysis System Product Portfolio
  12. 8.2.5 Roche Digital Pathology Recent Developments
  13. 8.3 3DHISTECH Ltd.
  14. 8.3.1 3DHISTECH Ltd. Company Information
  15. 8.3.2 3DHISTECH Ltd. Business Overview
  16. 8.3.3 3DHISTECH Ltd. Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  17. 8.3.4 3DHISTECH Ltd. Pathology Image Analysis System Product Portfolio
  18. 8.3.5 3DHISTECH Ltd. Recent Developments
  19. 8.4 Augmentiqs
  20. 8.4.1 Augmentiqs Company Information
  21. 8.4.2 Augmentiqs Business Overview
  22. 8.4.3 Augmentiqs Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Augmentiqs Pathology Image Analysis System Product Portfolio
  24. 8.4.5 Augmentiqs Recent Developments
  25. 8.5 microDimensions
  26. 8.5.1 microDimensions Company Information
  27. 8.5.2 microDimensions Business Overview
  28. 8.5.3 microDimensions Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  29. 8.5.4 microDimensions Pathology Image Analysis System Product Portfolio
  30. 8.5.5 microDimensions Recent Developments
  31. 8.6 Leica Biosystems
  32. 8.6.1 Leica Biosystems Company Information
  33. 8.6.2 Leica Biosystems Business Overview
  34. 8.6.3 Leica Biosystems Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Leica Biosystems Pathology Image Analysis System Product Portfolio
  36. 8.6.5 Leica Biosystems Recent Developments
  37. 8.7 Visiopharm
  38. 8.7.1 Visiopharm Company Information
  39. 8.7.2 Visiopharm Business Overview
  40. 8.7.3 Visiopharm Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Visiopharm Pathology Image Analysis System Product Portfolio
  42. 8.7.5 Visiopharm Recent Developments
  43. 8.8 Aiforia
  44. 8.8.1 Aiforia Company Information
  45. 8.8.2 Aiforia Business Overview
  46. 8.8.3 Aiforia Pathology Image Analysis System Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aiforia Pathology Image Analysis System Product Portfolio
  48. 8.8.5 Aiforia Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst